Menu Expand
Advances in Surgery, E-Book

Advances in Surgery, E-Book

John L. Cameron | Timothy G. Buchman | K. Craig Kent | Keith Lillemoe | Kelly M. McMasters | Mark Talamini | Charles J. Yeo

(2016)

Additional Information

Book Details

Abstract

Each year, Advances in Surgery reviews the most current practices in general surgery. A distinguished editorial board, headed by Dr. John Cameron, identifies key areas of major progress and controversy and invites preeminent specialists to contribute original articles devoted to these topics. These insightful overviews in general surgery bring concepts to a clinical level and explore their everyday impact on patient care.

Table of Contents

Section Title Page Action Price
Front Cover Cover
Advances In Surgery\r i
Volumes 1 through 45 (out of print) iii
Volume 49 iii
Volume 48 iv
Volume 47 v
Volume 46 vi
Copyright\r ix
CONTRIBUTORS\r xiii
CONTENTS\r xvii
Management of Mixed-Type Intraductal Papillary Mucinous Neoplasm xvii
Minimally Invasive Esophagectomy: Is There an Advantage? xvii
Optimal Management of the Axilla: A Look at the Evidence xviii
The Use of LINX for Gastroesophageal Reflux xviii
Bowel Preparation: Are Antibiotics Necessary for Colorectal Surgery? xviii
Incarcerated/Strangulated Hernia: Open or Laparoscopic? xix
Strategies to Reduce Postoperative Urinary Tract Infections xix
The Aging Surgeon xix
Maintenance of Certification xix
Treatment of Locally Advanced Pancreatic Ductal Adenocarcinoma xx
Prevention of Perioperative Anastomotic Healing Complications: Anastomotic Stricture and Anastomotic Leak xx
Is Health Services Research Important for Surgeons? xx
Robotic Colorectal Surgery: Advance or Expense? xxi
Ventilator Management: A Systematic Approach to Choosing and Using New Modes xxi
Hernia Management in the Athlete xxi
Groin Pain After Inguinal Hernia Repair xxii
Evolution of Sepsis Management: From Early Goal-Directed Therapy to Personalized Care xxii
Current Status of Carotid Stenting Versus Endarterectomy xxii
Management of Mixed-Type Intraductal Papillary Mucinous Neoplasm 1
Key points 1
INTRODUCTION 1
DEFINITION 2
Radiographic 2
Pathologic 3
CLINICOPATHOLOGIC CHARACTERISTICS 3
Epidemiology 3
Clinical and radiographic presentation 4
Pathology 4
CLASSIFICATION 4
Radiographic versus pathologic classification 4
Limitation of radiographic classification 5
Heterogeneity of main-duct involvement: proposed subclassifications of mixed-type intraductal papillary mucinous neoplasm 5
Pathologic subtype in mixed-type intraductal papillary mucinous neoplasm 6
NATURAL HISTORY 6
Malignancy risk 6
Surveillance 7
Predictors of malignancy 8
Survival and recurrence 9
MANAGEMENT 10
Indications for surgery 10
Surgical decision making 10
Nonsurgical management 12
SUMMARY 12
References 13
Minimally Invasive Esophagectomy 17
INTRODUCTION 17
HISTORICAL NOTE 18
RELATIONSHIP BETWEEN ANASTOMOTIC LEAK AND OPERATIVE MORTALITY 19
COMPARISON OF THE TRANSHIATAL AND TRANSTHORACIC ESOPHAGECTOMIES 21
MINIMALLY INVASIVE ESOPHAGECTOMY USING LAPAROSCOPIC AND THORACOSCOPIC TECHNIQUES 23
IS THERE AN OPTIMAL SURGICAL TECHNIQUE FOR PERFORMING ESOPHAGECTOMY? 24
DEVELOPMENT OF A MAXIMALLY EFFECTIVE ESOPHAGECTOMY 26
References 27
Optimal Management of the Axilla 29
INTRODUCTION 29
DEVELOPMENT OF LYMPHATIC MAPPING AND SENTINEL LYMPH NODE BIOPSY 30
Single-institution and multicenter studies of sentinel lymph node biopsy 30
Randomized trials of sentinel lymph node biopsy alone versus sentinel lymph node biopsy plus axillary lymph node dissection ... 31
Clinical significance of occult sentinel lymph node metastases 32
Randomized trials of sentinel lymph node biopsy alone versus sentinel lymph node biopsy plus axillary lymph node dissection ... 32
Assessment of axillary nodal status in patients treated with neoadjuvant chemotherapy 34
Sentinel lymph node biopsy in patients treated with neoadjuvant chemotherapy 34
Single-institution studies of sentinel lymph node biopsy after neoadjuvant chemotherapy 29
Multicenter studies of sentinel node biopsy after neoadjuvant chemotherapy 35
Meta-analysis of studies evaluating sentinel lymph node biopsy after neoadjuvant chemotherapy 35
Sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with known axillary involvement at diagnosis 35
Sentinel lymph node biopsy before neoadjuvant chemotherapy: advantages and limitations 37
References 38
The Use of LINX for Gastroesophageal Reflux 41
HISTORY 41
MAGNETIC ANTIREFLUX DEVICE 42
PATIENT SELECTION 43
SURGICAL TECHNIQUE 44
CONTRAINDICATIONS 45
EFFICACY 46
COMPLICATIONS 47
SUMMARY 47
References 47
Bowel Preparation 49
Key points 49
INTRODUCTION: BACKGROUND 49
SIGNIFICANCE 50
MECHANICAL BOWEL PREPARATION ALONE 51
COLONIC BACTERIA 53
MECHANICAL BOWEL PREPARATION PLUS ORAL ANTIBIOTICS 54
MECHANICAL BOWEL PREPARATION PLUS IV ANTIBIOTICS (WITH OR WITHOUT ORAL) 57
CURRENT EVIDENCE 58
RECTUM VERSUS COLON 61
ROLE OF ENEMA 62
LAPAROSCOPIC VERSUS OPEN 62
PRESENT RELEVANCE AND FUTURE AVENUES 62
SUMMARY 62
References 63
Incarcerated/Strangulated Hernia 67
INTRODUCTION 67
DIAGNOSIS 68
DECISION-MAKING 70
Incarcerated/strangulated inguinal hernia 70
SURGICAL APPROACHES—LAPAROSCOPY 71
Laparoscopic repair for adults 71
Laparoscopic repair for children 73
SURGICAL APPROACHES—OPEN 74
Open repair for adults 74
Open repair for children 75
SUMMARY 76
References 76
Strategies to Reduce Postoperative Urinary Tract Infections 79
INTRODUCTION 79
SIGNIFICANCE 80
PREVENTION OF CATHETER-ASSOCIATED URINARY TRACT INFECTION 82
Sterile catheter techniques 83
Types of catheters 84
Indications for catheterization 84
Timing of catheter removal 84
Reducing postoperative urinary retention 85
Prophylactic antibiotics 87
Screening for asymptomatic bacteriuria 87
SUMMARY 88
References 89
The Aging Surgeon 93
INTRODUCTION 93
CASE REPORT 94
IS THE AGING SURGEON STILL A PROBLEM? 94
ARE SURGEONS HUMAN? 95
IS A MANDATORY RETIREMENT AGE THE ANSWER? 97
BUT DOES THE SURGICAL PROFESSION POLICE ITSELF? 98
THE AGING SURGEON PROGRAM 99
SUMMARY 102
References 102
Maintenance of Certification 105
BACKGROUND 105
RECERTIFICATION ESTABLISHED 107
INTRODUCTION OF MAINTENANCE OF CERTIFICATION 107
REQUIREMENTS FOR THE AMERICAN BOARD OF SURGERY MAINTENANCE OF CERTIFICATION PROGRAM 109
RELEVANCE OF AMERICAN BOARD OF SURGERY MAINTENANCE OF CERTIFICATION 111
References 113
Treatment of Locally Advanced Pancreatic Ductal Adenocarcinoma 115
INTRODUCTION 115
SIGNIFICANCE OF RESECTABILITY 116
NEOADJUVANT CHEMOTHERAPY 117
FOLFIRINOX 117
Gemcitabine-based therapy 115
NEOADJUVANT CHEMORADIATION 119
SURGICAL RESECTION AND INTRAOPERATIVE THERAPY 120
Intraoperative Radiotherapy 121
Intraoperative Electroporation 122
ADJUVANT THERAPY 122
FUTURE DIRECTIONS 123
SUMMARY 124
References 124
Prevention of Perioperative Anastomotic Healing Complications 129
ANASTOMOTIC COMPLICATIONS: A SPECTRUM OF CLINICAL PRESENTATIONS 129
BEYOND TENSION AND ISCHEMIA: PHYSICS IS IMPORTANT, BUT BIOLOGY IS A MAJOR FACTOR IN ANASTOMOTIC HEALING 130
CURRENT UNDERSTANDING: WE HAVE PROBABILISTIC MEASUREMENTS AND WE NOW NEED DETERMINISTIC ANALYSES 131
Anastomotic stricture 131
Anastomotic leak 131
THE CHALLENGE OF DEFINING ANASTOMOTIC HEALING COMPLICATIONS 132
Anastomotic stricture 132
Anastomotic leak 133
SPECIFIC INTERVENTIONS TO PREVENT ANASTOMOTIC HEALING COMPLICATIONS 133
Anastomotic stricture 133
Anastomotic leak: hand sewn versus stapling, intraoperative evaluation, and diverting ileostomy 134
THE BIOLOGY OF ANASTOMOTIC HEALING 135
MICROBES: THE COMMON DENOMINATOR OF ANASTOMOTIC COMPLICATIONS? 136
PREPARING THE BOWEL FOR ANASTOMOTIC SURGERY: HOW WE GOT IT RIGHT, WHY WE STILL HAVE IT WRONG 137
SUMMARY: HOW DO WE MOVE FORWARD IN THE PREVENTION OF ANASTOMOTIC HEALING COMPLICATIONS? 138
References 139
Is Health Services Research Important for Surgeons? 143
INTRODUCTION 143
SIGNIFICANCE OF HEALTH SERVICES RESEARCH FOR SURGEONS 144
Defining health services research 144
A framework for health sciences research: structure, process, and outcomes 144
Structure 144
Process 146
Outcomes 147
Disciplines within health services research and research modalities 148
Patient/disease-management level 148
Hospital level 151
Health policy level 154
SUMMARY 154
References 155
Robotic Colorectal Surgery 157
INTRODUCTION 157
OPERATING IN CONFINES OF NARROW BONY PELVIS 158
IMPACT OF CONING ON CIRCUMFERENTIAL RESECTION MARGIN IN RECTAL CANCER 159
SUTURING AND KNOT-TYING 162
HAND-SEWN ILEOCOLIC ANASTOMOSES 163
RECTOPEXY 165
TRANSANAL MINIMALLY INVASIVE SURGERY 165
TRANSANAL TOTAL MESORECTAL EXCISION 166
SUMMARY 167
References 167
Ventilator Management 173
INTRODUCTION 173
SIGNIFICANCE 174
Initial approach 175
Hypoxia 175
High pressures 180
Dyssynchrony and comfort 182
Ventilator liberation 183
Present relevance and future avenues 184
SUMMARY 184
References 185
Hernia Management in the Athlete 187
Key points 187
BACKGROUND AND EPIDEMIOLOGY OF GROIN INJURIES 187
DIFFERENTIAL DIAGNOSIS 189
CLINICAL EVALUATION 191
DIAGNOSTIC EVALUATION AND IMAGING 192
PATHOPHYSIOLOGY OF ATHLETIC PUBALGIA 193
SURGICAL INDICATIONS AND OPERATIVE APPROACHES 194
Inguinal hernia 194
Athletic pubalgia 195
ROLE OF ADDUCTOR TENOTOMY 199
POSTOPERATIVE MANAGEMENT AND RETURN TO SPORT 200
SUMMARY 200
References 201
Groin Pain After Inguinal Hernia Repair 203
INTRODUCTION 203
SIGNIFICANCE 204
Definition 204
Etiology 204
Neuropathic pain 203
Relevant anatomy 205
Nonneuropathic pain 206
Visceral pain 206
Somatic pain 206
Risk factors 207
SYMPTOMATOLOGY AND DIAGNOSIS 208
History 208
Physical examination 208
Diagnostic imaging and tests 210
TREATMENT 211
Nonsurgical management 211
Interventional pain management 211
Nerve blocks 211
Neuroablative techniques 212
Neuromodulation 212
Surgical management 213
Selective versus triple neurectomy 213
Approach to open triple neurectomy 214
Approach to endoscopic retroperitoneal triple neurectomy 215
Surgical management of chronic postoperative inguinal pain with recurrence or meshoma 215
FUTURE DIRECTIONS 215
References 217
Evolution of Sepsis Management 221
Key points 221
DEFINITION OF SEPSIS 221
PATHOBIOLOGY OF SEPSIS 223
THERAPY FOR SEPSIS 225
EARLY GOAL-DIRECTED THERAPY 225
EFFICACY OF EARLY GOAL-DIRECTED THERAPY 227
WHY DID EARLY GOAL-DIRECTED THERAPY FAIL? 228
Changes in sepsis management over time 228
Efficacy of individual elements of early goal-directed therapy 229
Central venous pressure 221
Mean arterial pressure 229
Central venous oxygen saturation 230
Transfusion 230
PERSONALIZED CARE: TODAY 230
PERSONALIZED CARE: THE FUTURE 232
SUMMARY 232
References 232
Current Status of Carotid Stenting Versus Endarterectomy 235
Key points 235
REVIEW OF RANDOMIZED CONTROLLED CAROTID TRIALS (CAROTID ARTERY STENTING VS CAROTID ENDARTERECTOMY) 235
The Carotid and Vertebral Artery Transluminal Angioplasty Study 236
The Stenting and Angioplasty with Protection in Patients at High Risk for Endarterectomy Trial 236
The Endarterectomy Versus Angioplasty in Patients with Symptomatic Severe Carotid Stenosis Trial 237
The Stent-supported Percutaneous Angioplasty of the Carotid Artery Versus Endarterectomy Trial 237
The Carotid and Vertebral Artery Transluminal Angioplasty Study 2 (also called International Carotid Stenting Study) 238
Carotid Revascularization Endarterectomy Versus Stenting Trial 238
Metaanalysis of Clinical Trials: Carotid Artery Stenting Versus Carotid Endarterectomy 240
CAROTID ARTERY STENTING RESULTS IN THE REAL WORLD 243
Outcomes After Carotid Artery Stenting in Medicare Beneficiaries, 2005 to 2009 (Carotid Artery Stenting Linked to High Real ... 244
Comparison of Trends and Outcomes of Carotid Artery Stenting and Carotid Endarterectomy in the United States (2001–2010) 244
Comparative Effectiveness of Carotid Revascularization Treatment: Evidence from a National Hospital Discharge Database 246
Systematic Review and Metaanalysis of Carotid Artery Stenting Versus Endarterectomy for Carotid Stenosis: a Chronologic and ... 247
Repeat Carotid Endarterectomy Versus Carotid Artery Stenting for Patients with Restenosis After Carotid Endarterectomy: Sys ... 247
Society for Vascular Surgery Carotid Vascular Registry: Carotid Artery Stenting Versus Carotid Endarterectomy Outcome Compa ... 248
Other Negative Predictors for Carotid Artery Stenting 248
Effect of Age on Carotid Artery Stenting Results 248
Effect of Gender on Carotid Artery Stenting Results 249
Carotid Artery Stenting Is More Costly than Carotid Endarterectomy 249
Should the United States Centers for Medicare and Medicaid Services Extend Reimbursement Indications for Carotid Artery Ste ... 249
Guidelines of Various Specialties in Treating Carotid Artery Stenosis and the Differences in Their Recommendations for the ... 250
For Symptomatic Carotid Artery Stenosis 251
For Asymptomatic Carotid Artery Stenosis 251
Recent Carotid Artery Stenting Data: Using the Enroute Transcarotid System (Investigation of Transcarotid CAS With Dynamic ... 252
Final Recommendation for the Role of Carotid Artery Stenting Versus Carotid Endarterecomy 252
SUMMARY 253
References 253